Terms: = Lymphoma AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Diagnosis
14 results:
1. Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival.
Tao R; Chen Y; Kim S; Ocier K; Lloyd S; Poppe MM; Lee CJ; Glenn MJ; Smith KR; Fraser A; Deshmukh V; Newman MG; Snyder J; Rowe KG; Gaffney DK; Haaland B; Hashibe M
Cancer; 2022 Oct; 128(19):3564-3572. PubMed ID: 35916651
[TBL] [Abstract] [Full Text] [Related]
2. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.
Richter-Pechańska P; Kunz JB; Rausch T; Erarslan-Uysal B; Bornhauser B; Frismantas V; Assenov Y; Zimmermann M; Happich M; von Knebel-Doeberitz C; von Neuhoff N; Köhler R; Stanulla M; Schrappe M; Cario G; Escherich G; Kirschner-Schwabe R; Eckert C; Avigad S; Pfister SM; Muckenthaler MU; Bourquin JP; Korbel JO; Kulozik AE
Leukemia; 2022 Jul; 36(7):1759-1768. PubMed ID: 35585141
[TBL] [Abstract] [Full Text] [Related]
3. MAIT cell alterations in adults with recent-onset and long-term type 1 diabetes.
Nel I; Beaudoin L; Gouda Z; Rousseau C; Soulard P; Rouland M; Bertrand L; Boitard C; Larger E; Lehuen A
Diabetologia; 2021 Oct; 64(10):2306-2321. PubMed ID: 34350463
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis of Clinical Characteristics and Therapeutic Efficacy of Patients with Adult Acute Lymphoblastic Leukemia].
Xu TT; Wang WM; Fu GM; Wang JM; Jiang ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):68-75. PubMed ID: 32027255
[TBL] [Abstract] [Full Text] [Related]
5. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
[TBL] [Abstract] [Full Text] [Related]
6. Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.
Richter-Pechańska P; Kunz JB; Hof J; Zimmermann M; Rausch T; Bandapalli OR; Orlova E; Scapinello G; Sagi JC; Stanulla M; Schrappe M; Cario G; Kirschner-Schwabe R; Eckert C; Benes V; Korbel JO; Muckenthaler MU; Kulozik AE
Blood Cancer J; 2017 Feb; 7(2):e523. PubMed ID: 28157215
[TBL] [Abstract] [Full Text] [Related]
7. Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping.
Kagdi HH; Demontis MA; Fields PA; Ramos JC; Bangham CR; Taylor GP
Cancer Med; 2017 Jan; 6(1):298-309. PubMed ID: 28035765
[TBL] [Abstract] [Full Text] [Related]
8. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
[TBL] [Abstract] [Full Text] [Related]
9. Individualized leukemia cell-population profiles in common B-cell acute lymphoblastic leukemia patients.
Yu JH; Dong JT; Jia YQ; Jiang NG; Zeng TT; Xu H; Mo XM; Meng WT
Chin J Cancer; 2013 Apr; 32(4):213-23. PubMed ID: 22776235
[TBL] [Abstract] [Full Text] [Related]
10. Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study.
Cleaver AL; Beesley AH; Firth MJ; Sturges NC; O'Leary RA; Hunger SP; Baker DL; Kees UR
Mol Cancer; 2010 May; 9():105. PubMed ID: 20459861
[TBL] [Abstract] [Full Text] [Related]
11. Primary pancreatic lymphomas: a cytopathologic analysis of a rare malignancy.
Nayer H; Weir EG; Sheth S; Ali SZ
Cancer; 2004 Oct; 102(5):315-21. PubMed ID: 15386314
[TBL] [Abstract] [Full Text] [Related]
12. Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia.
Toze CL; Shepherd JD; Connors JM; Voss NJ; Gascoyne RD; Hogge DE; Klingemann HG; Nantel SH; Nevill TJ; Phillips GL; Reece DE; Sutherland HJ; Barnett MJ
Bone Marrow Transplant; 2000 Mar; 25(6):605-12. PubMed ID: 10734294
[TBL] [Abstract] [Full Text] [Related]
13. Myeloperoxidase positive acute lymphoblastic leukemia cell lines, NALM-30, NALM-31 and NALM-32, carrying Philadelphia chromosome with biphenotypic characteristics.
Matsuo Y; Sugimoto A; Harashima A; Nishizaki C; Drexler HG; Orita K
Hum Cell; 1998 Dec; 11(4):221-30. PubMed ID: 10363160
[TBL] [Abstract] [Full Text] [Related]
14. Proliferation of MIELIKI a novel t(7;9) early pre-B acute lymphoblastic leukemia cell line is inhibited concomitantly by IL-4 and IL-7.
Renard N; Duvert V; Matthews DJ; Pagés MP; Magaud JP; Manel AM; Pandrau-Garcia D; Philippe N; Banchereau J; Saeland S
Leukemia; 1995 Jul; 9(7):1219-26. PubMed ID: 7630198
[TBL] [Abstract] [Full Text] [Related]
